| Clearpath Hospice Llc 475 Wolf Ledges Parkway, Akron, OH, 44311 | |
| (330) 784-2162 |
News Archive
Enanta Pharmaceuticals, Inc. announced today the nomination of lead development candidate, EDP-239, from its NS5A hepatitis C virus (HCV) inhibitor program. EDP-239 has demonstrated picomolar potency against multiple genotypes of the virus and a preclinical pharmacokinetic profile amenable to once-a-day dosing.
The findings of Finnish scientists with their multinational collaborators shed light to the mechanisms of Parkinson's disease and early menopause.
A consortium of researchers headed by Cincinnati Children's Hospital Medical Center has discovered a gene expression pattern that could lead to improved diagnosis and treatment of pediatric septic shock , still a serious public health problem despite today's potent antibiotics and pediatric intensive care units.
A team of scientists from the University of Montreal and the Montreal Heart Institute Research Centre, led by Dr. Jean-Claude Tardif, has completed an important study that show how a new type of medication can lead to an improvement in the aortic valve narrowing
Antares Pharma, Inc. today announced positive results from an Actual Human Use (AHU) study for VIBEX Methotrexate (MTX).
› Verified 7 days ago
| Name | Clearpath Hospice Llc |
|---|---|
| Location | 475 Wolf Ledges Parkway, Akron, Ohio |
| Hospice ID | 361685 |
| Category | Freestanding Hospice |
| Ownership Type | Other |
| Profit Type | OTHER |
| Accreditation Provider | The Joint Commission (TJC) |
| SSA county code | 780 |
News Archive
Enanta Pharmaceuticals, Inc. announced today the nomination of lead development candidate, EDP-239, from its NS5A hepatitis C virus (HCV) inhibitor program. EDP-239 has demonstrated picomolar potency against multiple genotypes of the virus and a preclinical pharmacokinetic profile amenable to once-a-day dosing.
The findings of Finnish scientists with their multinational collaborators shed light to the mechanisms of Parkinson's disease and early menopause.
A consortium of researchers headed by Cincinnati Children's Hospital Medical Center has discovered a gene expression pattern that could lead to improved diagnosis and treatment of pediatric septic shock , still a serious public health problem despite today's potent antibiotics and pediatric intensive care units.
A team of scientists from the University of Montreal and the Montreal Heart Institute Research Centre, led by Dr. Jean-Claude Tardif, has completed an important study that show how a new type of medication can lead to an improvement in the aortic valve narrowing
Antares Pharma, Inc. today announced positive results from an Actual Human Use (AHU) study for VIBEX Methotrexate (MTX).
› Verified 7 days ago
| NPI Number | 1154751428 |
| Organization Name | Clearpath Hospice Llc |
| Address | 475 Wolf Ledges Pkwy Akron, Ohio, 44311 |
| Phone Number | (330)784-2162 |
News Archive
Enanta Pharmaceuticals, Inc. announced today the nomination of lead development candidate, EDP-239, from its NS5A hepatitis C virus (HCV) inhibitor program. EDP-239 has demonstrated picomolar potency against multiple genotypes of the virus and a preclinical pharmacokinetic profile amenable to once-a-day dosing.
The findings of Finnish scientists with their multinational collaborators shed light to the mechanisms of Parkinson's disease and early menopause.
A consortium of researchers headed by Cincinnati Children's Hospital Medical Center has discovered a gene expression pattern that could lead to improved diagnosis and treatment of pediatric septic shock , still a serious public health problem despite today's potent antibiotics and pediatric intensive care units.
A team of scientists from the University of Montreal and the Montreal Heart Institute Research Centre, led by Dr. Jean-Claude Tardif, has completed an important study that show how a new type of medication can lead to an improvement in the aortic valve narrowing
Antares Pharma, Inc. today announced positive results from an Actual Human Use (AHU) study for VIBEX Methotrexate (MTX).
› Verified 7 days ago
| Quality Measure | Provider Score | National Score |
|---|---|---|
| Patients or caregivers who were asked about treatment preferences like hospitalization and resuscitation at the beginning of hospice care | 98.8 | 98.3 |
| Patients or caregivers who were asked about their beliefs and values at the beginning of hospice care | 90.4 | 93.6 |
| Patients who were checked for pain at the beginning of hospice care | 91.6 | 93.9 |
| Patients who got a timely and thorough pain assessment when pain was identified as a problem | 71.4 | 77.7 |
| Patients who were checked for shortness of breath at the beginning of hospice care | 72.3 | 97.3 |
| Patients who got timely treatment for shortness of breath | Not Available | 94.6 |
| Patients taking opioid pain medication who were offered care for constipation | 90.0 | 93.3 |
News Archive
Enanta Pharmaceuticals, Inc. announced today the nomination of lead development candidate, EDP-239, from its NS5A hepatitis C virus (HCV) inhibitor program. EDP-239 has demonstrated picomolar potency against multiple genotypes of the virus and a preclinical pharmacokinetic profile amenable to once-a-day dosing.
The findings of Finnish scientists with their multinational collaborators shed light to the mechanisms of Parkinson's disease and early menopause.
A consortium of researchers headed by Cincinnati Children's Hospital Medical Center has discovered a gene expression pattern that could lead to improved diagnosis and treatment of pediatric septic shock , still a serious public health problem despite today's potent antibiotics and pediatric intensive care units.
A team of scientists from the University of Montreal and the Montreal Heart Institute Research Centre, led by Dr. Jean-Claude Tardif, has completed an important study that show how a new type of medication can lead to an improvement in the aortic valve narrowing
Antares Pharma, Inc. today announced positive results from an Actual Human Use (AHU) study for VIBEX Methotrexate (MTX).
› Verified 7 days ago
| Home Health Aides | 3 |
| Counselors | 1 |
| Medical Social Workers | 2 |
| Physicians | 1 |
| Registered Nurses | 3 |
| Other Personnel | 1 |
| Total Employees | 11 |
|---|
News Archive
Enanta Pharmaceuticals, Inc. announced today the nomination of lead development candidate, EDP-239, from its NS5A hepatitis C virus (HCV) inhibitor program. EDP-239 has demonstrated picomolar potency against multiple genotypes of the virus and a preclinical pharmacokinetic profile amenable to once-a-day dosing.
The findings of Finnish scientists with their multinational collaborators shed light to the mechanisms of Parkinson's disease and early menopause.
A consortium of researchers headed by Cincinnati Children's Hospital Medical Center has discovered a gene expression pattern that could lead to improved diagnosis and treatment of pediatric septic shock , still a serious public health problem despite today's potent antibiotics and pediatric intensive care units.
A team of scientists from the University of Montreal and the Montreal Heart Institute Research Centre, led by Dr. Jean-Claude Tardif, has completed an important study that show how a new type of medication can lead to an improvement in the aortic valve narrowing
Antares Pharma, Inc. today announced positive results from an Actual Human Use (AHU) study for VIBEX Methotrexate (MTX).
› Verified 7 days ago
| Others | 1 |
| Total Volunteers | 1 |
|---|
News Archive
Enanta Pharmaceuticals, Inc. announced today the nomination of lead development candidate, EDP-239, from its NS5A hepatitis C virus (HCV) inhibitor program. EDP-239 has demonstrated picomolar potency against multiple genotypes of the virus and a preclinical pharmacokinetic profile amenable to once-a-day dosing.
The findings of Finnish scientists with their multinational collaborators shed light to the mechanisms of Parkinson's disease and early menopause.
A consortium of researchers headed by Cincinnati Children's Hospital Medical Center has discovered a gene expression pattern that could lead to improved diagnosis and treatment of pediatric septic shock , still a serious public health problem despite today's potent antibiotics and pediatric intensive care units.
A team of scientists from the University of Montreal and the Montreal Heart Institute Research Centre, led by Dr. Jean-Claude Tardif, has completed an important study that show how a new type of medication can lead to an improvement in the aortic valve narrowing
Antares Pharma, Inc. today announced positive results from an Actual Human Use (AHU) study for VIBEX Methotrexate (MTX).
› Verified 7 days ago
| Hospice Of Visiting Nurse Service Location: 3358 Ridgewood Road, Akron, Ohio, 44333 Phone: (330) 784-2162 |
| Hospice Of Summa And Summa At Home Hospice Service Location: 1077 Gorge Blvd, Akron, Ohio, 44310 Phone: (330) 784-2162 |
| Great Lakes Caring Location: 1530 West Market Street, Akron, Ohio, 44313 Phone: (330) 784-2162 |
| Compassionate Care Hospice Location: 300 North Cleveland Massillon Rd, Ste 103, Akron, Ohio, 44333 Phone: (330) 784-2162 |